Jane A. Wakeman

736 citations
25 papers · 526 indexed · h-index 14
Topics
RNA modifications and cancer (7 papers)RNA Research and Splicing (5 papers)Cancer-related gene regulation (4 papers)

In The Last Decade

Jane A. Wakeman

25 papers receiving 511 citations

Peers

Jane A. Wakeman
Comparison fields: 5 of 70
  • Molecular Biology 410
  • Cancer Research 72
  • Genetics 68
  • Oncology 67
  • Immunology 46
Replace Cristina Aguilera with:
Cristina Aguilera Spain
Jackson A. Hoffman United States
Irène Aksoy France
Adrienne L. Watson United States
Abhishek Sampath Kumar United States
Catherine A. Cremona United Kingdom
Borko Tanasijevic Canada
Rieko Ajima Japan
Kira Orlovsky Israel
Vincent van den Boom Netherlands
Jane A. Wakeman relative to Cristina Aguilera Spain Cristina Aguilera's profile →
Citations per field
00.5×1.5×2.1×
Cristina Aguilera · 1×
Citations per year

Countries citing papers authored by Jane A. Wakeman

Since Specialization
Citations

This map shows the geographic impact of Jane A. Wakeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane A. Wakeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane A. Wakeman more than expected).

Fields of papers citing papers by Jane A. Wakeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane A. Wakeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane A. Wakeman. The network helps show where Jane A. Wakeman may publish in the future.

Co-authorship network of co-authors of Jane A. Wakeman

This figure shows the co-authorship network connecting the top 25 collaborators of Jane A. Wakeman. A scholar is included among the top collaborators of Jane A. Wakeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane A. Wakeman. Jane A. Wakeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 6
4 20
5 47
6 8
7 13
8 22
9 1
10 48
11 51
12 10
13 26
14 1
15 11
16 13
17 27
18 9
19 25
20 89

About Jane A. Wakeman

Jane A. Wakeman is a scholar working on Aging, Molecular Biology and Cancer Research, having authored 25 papers that have together received 526 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), RNA Research and Splicing (5 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Molecular Biology (410 citations), Cancer Research (72 citations) and Aging (6 citations). Jane A. Wakeman has collaborated with scholars based in United Kingdom, Austria and United States. Frequent co-authors include Ramsay J. McFarlane, B.E.H. Maden, T. Farrell, Peter W. Andrews, Carolyn L. Dent, Julia Feichtinger, N Stuart, Debalina Sarkar, Lee Larcombe and Jürgen Müller. Their work appears in journals such as Cancer Research, Oncogene and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026